Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Diamond

Concepts (270)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
11
2021
149
5.210
Why?
Breast Neoplasms
17
2021
1925
3.580
Why?
Pyrimidines
9
2021
408
2.850
Why?
Antineoplastic Combined Chemotherapy Protocols
14
2022
1390
2.520
Why?
Antineoplastic Agents
20
2020
2035
2.510
Why?
Neoplasms
14
2022
2065
2.050
Why?
Immunoconjugates
5
2021
86
2.000
Why?
Receptor, ErbB-2
8
2021
328
1.950
Why?
Paclitaxel
6
2022
201
1.920
Why?
Pyrazoles
6
2021
399
1.640
Why?
Protein Kinase Inhibitors
9
2022
853
1.600
Why?
Ovarian Neoplasms
4
2020
350
1.590
Why?
Camptothecin
6
2022
90
1.580
Why?
Quinoxalines
2
2020
69
1.560
Why?
Azepines
3
2020
80
1.500
Why?
Piperazines
3
2020
328
1.500
Why?
Antibodies, Monoclonal, Humanized
8
2021
654
1.380
Why?
Neutropenia
4
2022
130
1.080
Why?
Gene Expression Regulation, Neoplastic
5
2020
1199
0.940
Why?
beta Catenin
2
2020
221
0.900
Why?
Breast Neoplasms, Male
2
2018
31
0.890
Why?
Xenograft Model Antitumor Assays
10
2021
779
0.870
Why?
Cancer Care Facilities
1
2020
32
0.830
Why?
Maximum Tolerated Dose
9
2022
189
0.830
Why?
Benzoxazoles
1
2020
23
0.820
Why?
Histone Deacetylase Inhibitors
1
2022
201
0.810
Why?
Carcinoma, Lobular
2
2018
59
0.800
Why?
Lymphocytes, Tumor-Infiltrating
1
2020
116
0.790
Why?
eIF-2 Kinase
1
2019
29
0.780
Why?
Cyclin-Dependent Kinase 4
1
2018
36
0.730
Why?
Cyclin-Dependent Kinase 6
1
2018
36
0.720
Why?
Wnt Signaling Pathway
1
2019
138
0.690
Why?
Drug Resistance, Neoplasm
4
2020
681
0.690
Why?
Aurora Kinase A
4
2020
58
0.680
Why?
Female
41
2021
63070
0.670
Why?
Tumor Microenvironment
1
2020
393
0.670
Why?
Carcinoma, Ductal, Breast
1
2018
92
0.670
Why?
Pyrazines
2
2018
81
0.650
Why?
Colonic Neoplasms
1
2018
216
0.620
Why?
Neoadjuvant Therapy
1
2018
283
0.610
Why?
Humans
50
2022
114571
0.600
Why?
Angiopoietin-1
1
2015
9
0.590
Why?
Angiopoietin-2
1
2015
14
0.590
Why?
Tumor Suppressor Protein p53
3
2016
460
0.550
Why?
Aged
20
2021
20218
0.550
Why?
Uterine Cervical Neoplasms
1
2017
204
0.540
Why?
Middle Aged
23
2021
28854
0.500
Why?
Tumor Suppressor Proteins
1
2015
284
0.480
Why?
Proto-Oncogene Proteins c-met
1
2013
72
0.480
Why?
Treatment Outcome
12
2022
9190
0.470
Why?
Adult
23
2022
32077
0.470
Why?
Point Mutation
1
2013
241
0.460
Why?
Cell Proliferation
8
2020
2368
0.460
Why?
Cell Line, Tumor
7
2020
2887
0.460
Why?
Dose-Response Relationship, Drug
6
2022
2187
0.460
Why?
Triazoles
1
2013
141
0.450
Why?
Recombinant Fusion Proteins
1
2015
694
0.450
Why?
Angiogenesis Inhibitors
3
2018
221
0.430
Why?
Carcinoma, Renal Cell
1
2013
175
0.430
Why?
Neoplasm Recurrence, Local
4
2021
805
0.420
Why?
Mitochondria
1
2017
816
0.420
Why?
Clinical Trials, Phase I as Topic
2
2020
53
0.420
Why?
Trastuzumab
3
2021
104
0.410
Why?
Genes, BRCA2
1
2009
22
0.400
Why?
Genes, BRCA1
1
2009
27
0.400
Why?
Neoplasm Metastasis
4
2020
610
0.400
Why?
Nuclear Proteins
1
2015
634
0.390
Why?
Biomarkers, Tumor
2
2014
1051
0.390
Why?
BRCA2 Protein
1
2009
37
0.380
Why?
Mice, Nude
5
2020
696
0.380
Why?
Pregnancy Complications, Neoplastic
1
2009
54
0.370
Why?
Kidney Neoplasms
1
2013
330
0.370
Why?
Chemotherapy, Adjuvant
2
2021
327
0.370
Why?
Thrombophilia
1
2009
72
0.370
Why?
Aged, 80 and over
8
2020
6818
0.370
Why?
Neoplasm Staging
5
2021
1215
0.370
Why?
Molecular Targeted Therapy
3
2019
380
0.370
Why?
Quinolines
2
2021
140
0.360
Why?
Aromatase Inhibitors
2
2018
52
0.360
Why?
Receptors, Progesterone
2
2021
337
0.330
Why?
DNA-Binding Proteins
1
2015
1421
0.330
Why?
Antibodies, Monoclonal
3
2020
1294
0.320
Why?
Mice
9
2021
15429
0.320
Why?
Receptors, Estrogen
2
2021
390
0.320
Why?
Antineoplastic Agents, Immunological
2
2019
155
0.310
Why?
Models, Biological
1
2014
1807
0.300
Why?
Liver Neoplasms
1
2009
457
0.290
Why?
Colorectal Neoplasms
3
2018
589
0.280
Why?
Apoptosis
5
2020
2607
0.270
Why?
Lung Neoplasms
1
2017
2191
0.260
Why?
Cyclophosphamide
2
2018
232
0.260
Why?
Radiosurgery
2
2019
299
0.250
Why?
Doxorubicin
2
2018
313
0.240
Why?
Cyclin-Dependent Kinase 9
1
2022
10
0.240
Why?
Histones
2
2022
540
0.230
Why?
Histone Deacetylase 1
1
2022
19
0.230
Why?
Biopsy
2
2018
1048
0.230
Why?
Aurora Kinases
2
2012
34
0.230
Why?
Topoisomerase I Inhibitors
2
2022
16
0.230
Why?
Disease Progression
4
2019
2486
0.230
Why?
Anthracyclines
1
2021
33
0.230
Why?
Administration, Oral
3
2022
796
0.230
Why?
Animals
10
2021
34687
0.220
Why?
Taxoids
1
2021
94
0.220
Why?
Acetylation
1
2022
222
0.220
Why?
Biliary Tract Neoplasms
1
2021
22
0.220
Why?
Androstadienes
1
2021
102
0.210
Why?
Carboplatin
1
2021
140
0.210
Why?
Diarrhea
2
2019
176
0.210
Why?
Heterografts
1
2021
130
0.210
Why?
Necrosis
2
2019
227
0.210
Why?
Male
14
2021
60817
0.210
Why?
Fatigue
2
2022
301
0.210
Why?
Hospitals, University
1
2021
193
0.210
Why?
Drug Administration Schedule
3
2017
808
0.200
Why?
Histone Deacetylases
1
2022
208
0.200
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
53
0.200
Why?
Benzodiazepines
1
2021
106
0.200
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
98
0.200
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
25
0.200
Why?
Medicare
2
2021
664
0.200
Why?
Immune System
1
2021
196
0.190
Why?
Kaplan-Meier Estimate
1
2021
899
0.180
Why?
Aquaporin 4
1
2019
70
0.180
Why?
Albumins
1
2019
98
0.180
Why?
Maintenance Chemotherapy
1
2018
24
0.180
Why?
Antibodies, Bispecific
1
2018
28
0.180
Why?
Tumor Cells, Cultured
1
2020
1002
0.180
Why?
Nausea
1
2018
116
0.170
Why?
Aminopyridines
1
2018
90
0.170
Why?
Vascular Endothelial Growth Factor A
2
2018
518
0.170
Why?
Mastectomy
1
2018
114
0.170
Why?
Breast
1
2018
148
0.170
Why?
G2 Phase Cell Cycle Checkpoints
2
2018
34
0.170
Why?
Benzimidazoles
1
2018
145
0.170
Why?
Topotecan
1
2017
13
0.170
Why?
Drug Therapy, Combination
1
2020
1004
0.170
Why?
Purines
1
2018
166
0.170
Why?
Mice, Inbred BALB C
1
2020
1315
0.170
Why?
Radiotherapy, Adjuvant
1
2018
194
0.170
Why?
Isoflavones
1
2017
26
0.170
Why?
Calcium-Binding Proteins
1
2018
215
0.160
Why?
Carbolines
1
2017
33
0.160
Why?
Disease Models, Animal
2
2021
3828
0.160
Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
15
0.160
Why?
Imidazoles
1
2018
264
0.160
Why?
Inhibitory Concentration 50
2
2016
80
0.160
Why?
Immunotherapy
1
2021
459
0.160
Why?
Nanoparticles
1
2021
333
0.160
Why?
Insulin-Like Growth Factor I
1
2018
275
0.160
Why?
Survival Analysis
1
2020
1410
0.160
Why?
Neoplasms, Radiation-Induced
1
2016
77
0.150
Why?
Hypertension
2
2018
1186
0.150
Why?
Neoplasms, Second Primary
1
2016
73
0.150
Why?
GPI-Linked Proteins
1
2016
56
0.150
Why?
Retrospective Studies
3
2021
11642
0.150
Why?
Cell Survival
1
2019
1134
0.150
Why?
Adaptor Proteins, Signal Transducing
1
2018
387
0.150
Why?
Tumor Protein p73
1
2015
17
0.150
Why?
Antibodies, Neoplasm
1
2015
32
0.140
Why?
Hodgkin Disease
1
2016
117
0.140
Why?
Risk Reduction Behavior
1
2016
220
0.140
Why?
Phosphorylation
1
2019
1728
0.140
Why?
Maytansine
1
2014
14
0.140
Why?
Pyridines
1
2018
498
0.140
Why?
Demography
1
2015
285
0.130
Why?
Brain Edema
1
2014
66
0.130
Why?
Randomized Controlled Trials as Topic
1
2019
1159
0.130
Why?
Drug Interactions
1
2015
402
0.130
Why?
Analgesics, Opioid
1
2021
717
0.130
Why?
Survival Rate
2
2019
1859
0.130
Why?
Threonine
1
2013
53
0.130
Why?
Sulfones
1
2014
104
0.130
Why?
Protein Kinases
1
2015
334
0.130
Why?
Glycine
1
2014
159
0.120
Why?
Tumor Stem Cell Assay
1
2012
39
0.120
Why?
Drug Evaluation, Preclinical
1
2013
196
0.120
Why?
Methionine
1
2013
158
0.120
Why?
Heterozygote
1
2013
257
0.120
Why?
Computational Biology
1
2015
473
0.120
Why?
Drug Design
1
2013
171
0.120
Why?
Treatment Failure
1
2013
334
0.110
Why?
Disease-Free Survival
1
2014
685
0.110
Why?
In Situ Hybridization, Fluorescence
1
2013
340
0.110
Why?
Time Factors
2
2020
7029
0.110
Why?
Cellular Senescence
1
2012
147
0.110
Why?
Neovascularization, Pathologic
1
2013
295
0.110
Why?
Carcinoma in Situ
1
2011
43
0.110
Why?
Cluster Analysis
1
2012
467
0.110
Why?
Cell Transformation, Neoplastic
1
2013
339
0.110
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
87
0.100
Why?
Risk Assessment
1
2020
3208
0.100
Why?
Brain Neoplasms
2
2019
982
0.100
Why?
Receptor Protein-Tyrosine Kinases
1
2013
276
0.100
Why?
Mutation
2
2012
3378
0.100
Why?
United States
3
2021
12551
0.100
Why?
Colorado
1
2020
4488
0.100
Why?
Sequence Analysis, DNA
1
2013
734
0.100
Why?
Tumor Burden
1
2010
288
0.100
Why?
Pregnancy Trimester, Second
1
2009
81
0.100
Why?
Mastectomy, Segmental
1
2009
89
0.090
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
52
0.090
Why?
Keratinocytes
1
2010
243
0.090
Why?
Pregnancy Trimester, First
1
2009
121
0.090
Why?
Clinical Trials as Topic
2
2013
1004
0.090
Why?
Lymph Node Excision
1
2009
143
0.090
Why?
Apoptosis Regulatory Proteins
1
2009
212
0.090
Why?
Infusions, Intravenous
2
2019
406
0.080
Why?
Cell Adhesion Molecules
2
2019
184
0.080
Why?
Risk Factors
1
2020
9078
0.080
Why?
Antigens, Neoplasm
2
2019
230
0.080
Why?
Prognosis
2
2018
3546
0.080
Why?
Risk
1
2009
943
0.080
Why?
Gene Expression Profiling
1
2012
1561
0.070
Why?
Cell Cycle
2
2018
589
0.070
Why?
Combined Modality Therapy
2
2019
1217
0.060
Why?
Mesylates
1
2022
6
0.060
Why?
Signal Transduction
2
2014
4890
0.060
Why?
Chimerism
1
2021
28
0.050
Why?
Lymphoid Tissue
1
2021
60
0.050
Why?
Lymphocyte Subsets
1
2021
83
0.050
Why?
Liver
1
2009
1832
0.050
Why?
Mice, SCID
1
2021
357
0.050
Why?
SEER Program
1
2021
206
0.050
Why?
Mice, Inbred NOD
1
2021
561
0.050
Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.050
Why?
Infant, Newborn
1
2009
5045
0.050
Why?
Pregnancy
1
2009
5267
0.040
Why?
Tissue Distribution
1
2018
365
0.040
Why?
Anemia
1
2019
163
0.040
Why?
Retreatment
1
2016
70
0.040
Why?
Platinum
1
2016
31
0.040
Why?
Cetuximab
1
2016
97
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
122
0.040
Why?
Neoplasm Transplantation
1
2016
262
0.040
Why?
Drug Screening Assays, Antitumor
1
2016
190
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2021
552
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
238
0.040
Why?
History, Ancient
1
2015
44
0.040
Why?
Opioid-Related Disorders
1
2021
326
0.040
Why?
Databases, Genetic
1
2015
171
0.030
Why?
Biomarkers
2
2016
3485
0.030
Why?
DNA Damage
1
2017
365
0.030
Why?
Mice, Knockout
1
2021
2835
0.030
Why?
Phenotype
1
2021
2842
0.030
Why?
Drug Combinations
1
2013
303
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
230
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2015
405
0.030
Why?
Immunohistochemistry
1
2016
1783
0.030
Why?
Cohort Studies
1
2021
5000
0.030
Why?
Biopsy, Needle
1
2011
194
0.030
Why?
HT29 Cells
1
2010
38
0.030
Why?
Ki-67 Antigen
1
2010
108
0.020
Why?
Transcription, Genetic
1
2017
1460
0.020
Why?
ErbB Receptors
1
2013
553
0.020
Why?
Cell Cycle Proteins
1
2014
571
0.020
Why?
Capillary Permeability
1
2010
162
0.020
Why?
Enzyme Inhibitors
1
2014
930
0.020
Why?
Protein-Tyrosine Kinases
1
2013
446
0.020
Why?
Proto-Oncogene Proteins
1
2014
713
0.020
Why?
Patient Satisfaction
1
2013
610
0.020
Why?
Patient Selection
1
2013
707
0.020
Why?
Follow-Up Studies
1
2018
4950
0.020
Why?
Membrane Proteins
1
2015
1083
0.020
Why?
Algorithms
1
2015
1502
0.020
Why?
Positron-Emission Tomography
1
2010
303
0.020
Why?
Magnetic Resonance Imaging
1
2019
3145
0.020
Why?
Tomography, X-Ray Computed
1
2016
2379
0.020
Why?
Brain
1
2014
2711
0.010
Why?
Young Adult
1
2014
10987
0.010
Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)